Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 21.2% – Here’s Why

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shares were up 21.2% during mid-day trading on Thursday . The stock traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares changed hands during trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Price Performance

The firm has a market cap of C$27.89 million, a PE ratio of -20.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock’s fifty day moving average price is C$0.10 and its 200-day moving average price is C$0.07.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Articles

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.